Geographic · Other long-lived assets
Asia — Other long-lived assets
Biogen Asia — Other long-lived assets decreased by 30.6% to $5.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 30.6%, from $8.50M to $5.90M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2025
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital expansion or infrastructure investment in the region, while a decrease may indicate asset depreciation, divestiture, or a shift in regional operational strategy.
Detailed definition
This metric represents the net book value of non-current, non-financial assets held by the company within the Asian geog...
Peer comparison
Comparable to 'Property, Plant, and Equipment' or 'Non-current Assets' reported by geographic segment in peer pharmaceutical companies' annual reports.
Metric ID:
biib_segment_asia_other_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $16.40M | $13.70M | $8.30M | $8.50M | $5.90M |
| QoQ Change | — | -16.5% | -39.4% | +2.4% | -30.6% |
| YoY Change | — | -16.5% | -39.4% | +2.4% | -30.6% |
Range$5.90M – $16.40M
CAGR-64.0%
Avg YoY Growth-21.0%
Median YoY Growth-23.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's asia — other long-lived assets?
- Biogen (BIIB) reported asia — other long-lived assets of $5.90M in Q4 2025.
- How has Biogen's asia — other long-lived assets changed year-over-year?
- Biogen's asia — other long-lived assets decreased by 30.6% year-over-year, from $8.50M to $5.90M.
- What does asia — other long-lived assets mean?
- The total value of long-term, non-financial assets owned by the company in the Asian region.